Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

China · Delayed Price · Currency is CNY

49.27

-3.30 (-6.28%)

Aug 21, 2026, 3:00 PM CST

58.22% (1Y)

Market Cap	33.21B +52.9%
Revenue (ttm)	1.69B -14.9%
Net Income	495.08M +27.8%
EPS	0.68 +33.4%
Shares Out	733.37M
PE Ratio	72.17
Forward PE	77.52
Dividend	0.12 (0.23%)
Ex-Dividend Date	Jun 30, 2026

Volume	51,907,934
Open	50.24
Previous Close	52.57
Day's Range	48.66 - 51.46
52-Week Range	26.25 - 55.68
Beta	0.82
Analysts	Buy
Price Target	34.17 (-30.65%)
Earnings Date	Aug 28, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1995

Employees 2,649

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603127

Full Company Profile

Financial Performance

In 2025, SHA:603127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 603127 stock is "Buy." The 12-month stock price target is ¥34.17, which is a decrease of -30.65% from the latest price.

Price Target

¥34.17

(-30.65% downside)

Analyst Consensus: Buy

Stock Forecasts